Ibrance
Market Access/ News/ News/ News/ News/ Oncology/ Patients/ Top stories
NICE backs Ibrance for breast cancer via Cancer Drugs Fund
Phil Taylor
breast cancer, Ibrance, NICE, Oncology, Pfizer
0 Comment
X
NICE backs Ibrance for breast cancer via Cancer Drugs Fund
https://pharmaphorum.com/news/nice-backs-ibrance-for-breast-cancer-via-cancer-drugs-fund/
X
Scotland backs Pfizer’s Ibrance for breast cancer
https://pharmaphorum.com/news/scotland-backs-pfizers-ibrance-for-breast-cancer/
X
Real-world data unlocks Ibrance ok in male breast cancer
https://pharmaphorum.com/news/real-world-data-unlocks-ibrance-ok-in-male-breast-cancer/
ASCO-contributor/ Oncology/ Partner content/ Partner Content/ Pharma Market Access/ Press releases
Ibrance approval cemented as competition comes into view
Tari Awipi and Arnold DuBell
asco, breast cancer, Ibrance, kantar health, metastatic, pharma
0 Comment
X
Ibrance approval cemented as competition comes into view
https://pharmaphorum.com/partner-content-oncology/ibrance-approval-cemented-competition-comes-view/